SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Brightcove Inc. (BCOV) .
Criteria proven by this page:
- VALUE (10/100, Fail) — analyst consensus target implies downside from the current price ($3.50, 21.3%).
- Analyst consensus target $3.50 (-21.3% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 25/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BCOV
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.95
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.53
Book Value / Share$0.00
Revenue / Share$4.66
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$3.50 (-21.3%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$-0.53 |
$125.02M |
$-16.89M |
-13.5% |
| 2015 |
$-0.23 |
$134.71M |
$-7.58M |
-5.6% |
| 2016 |
$-0.30 |
$150.27M |
$-9.99M |
-6.6% |
| 2017 |
$-0.57 |
$155.91M |
$-19.52M |
-12.5% |
| 2018 |
$-0.39 |
$164.83M |
$-14.03M |
-8.5% |
| 2019 |
$-0.58 |
$184.46M |
$-21.9M |
-11.9% |
| 2020 |
$-0.15 |
$197.35M |
$-5.81M |
-2.9% |
| 2021 |
$0.13 |
$211.09M |
$5.4M |
2.6% |
| 2022 |
$-0.22 |
$211.01M |
$-9.02M |
-4.3% |
| 2023 |
$-0.53 |
$201.19M |
$-22.89M |
-11.4% |
